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ABSTRACT: Octamethylcyclotetrasiloxane (D4) and deca-
methylpentasiloxane (D5) are used as ingredients for personal
care products (PCPs). Because of the use of these PCPs,
consumers are exposed daily to D4 and D5. A sensitive
analytical method was developed for analysis of D4 and D5 in
end-exhaled air by thermal desorption gas chromatography
mass spectrometry (TD-GC-MS), to determine the internal
dose for consumer exposure assessment. Fifteen consumers
provided end-exhaled air samples that were collected using
Bio-VOC breath samplers and subsequently transferred to
automatic thermal desorption (ATD) tubes. Prior to use, the
ATD tubes were conditioned for a minimum of 4 h at 350 °C.
The TD unit and auto sampler were coupled to a GC-MS using electron ionization. Calibration was performed using
0−10 ng/μL solutions of D4/D5 and 13C-labeled D4/D5 as internal standards. The ions monitored were m/z 281 for D4,
355 for D5, 285 for 13C-labeled D4, and 360 for 13C-labeled D5. The addition of internal standard reduced the coeﬃcient of
variation from 30.8% to 9.5% for D4 and from 37.8% to 12.5% for D5. The limit of quantiﬁcation was 2.1 ng/L end-exhaled air
for D4 and 1.4 ng/L end-exhaled air for D5. With this method, cyclic siloxanes (D4 and D5) can be quantiﬁed in end-exhaled air
at concentrations as low as background levels observed in the general population.
On a daily basis, consumers are exposed to cyclic siloxanes,such as octamethylcyclotetrasiloxane (D4) and decame-
thylcyclopentasiloxane (D5), via the use of personal care
products (PCPs).1,2 These substances are added to PCPs as
emollient or solvent.3,4 Some PCPs are used with a high frequency
(e.g., deodorant or day cream once a day).5 Often multiple
products are used simultaneously, leading to aggregate exposure
(i.e., simultaneous exposure to the same substance from all
possible sources and routes).6,7 For example, D4 or D5 present in
a deodorant or day cream could be inhaled when applying the
product and could be dermally absorbed as the product stays on
the skin during the day.
The widely investigated toxicity of D4 and D5 has recently
been reviewed by the Scientiﬁc Committee on Consumer
Safety (SCCS) of the European Union4 and the Cosmetic
Ingredient Review (CIR) expert panel in the United States.3
Both committees state that the use of D4 and D5 in PCPs
represents a minimal human health risk. However, data to
assess the potential health risks of aggregate exposure were not
available and therefore not included in the assessment.
The majority of D4 and D5 that becomes systemically
available, either through inhalation or dermal absorption, is
eliminated by exhalation of the parent compound.8 A small
fraction is metabolized and excreted in urine.9,10 D4 and D5
were quantiﬁed using GC-MS in diﬀerent biological media,
such as blood and urine.11−13 Their vapor pressures (Table 1)
and low blood:air partition coeﬃcients make them suitable for
detection in end-exhaled air.14,15 Plotzke and co-workers
studied 13C−D4 and 13C−D5 concentrations in exhaled
air.16,17 Tedlar bags were used for sample collection and the
substances of interest were trapped on Tenax adsorbent tubes,
desorbed with pure hexane, and analyzed by GC-MS. Recently,
Pieri and colleagues determined the presence of linear and
cyclic volatile methyl siloxanes (D3 to D6) in indoor air using
TD-GC-MS.18 To our knowledge, our method is the ﬁrst
describing the use of TD-GC-MS as an analytical technique to
quantify native cyclic siloxanes in end-exhaled air.
The concept of sampling volatile organic compounds
(VOCs) in end-exhaled air is brieﬂy introduced below. The
basic concept described by Farhi19 has been adjusted as we
assume that VOCs are present in ambient air, leading to
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inhalation of the substance. Under steady-state conditions, the
amount of VOC entering the lung via venous blood equals the
diﬀerence between the amount of VOC entering and leaving
the lung via inhalation or exhalation (CA − Cin) and the amount
of VOC leaving via arterial blood and can be described
according to the following mass balance (eq 1):
× = × − + ×Q C V C C Q C( )C V A A in C art (1)
where QC is the cardiac output (L/min), CV is the venous blood
concentration (ng/L), VA is the ventilation rate (L/min), CA is
the alveolar concentration during exhalation (ng/L), Cin the
concentration in inhaled air (ng/L), and Cart is the arterial
blood concentration (ng/L).
The arterial blood concentration is depending on the
blood:air partition coeﬃcient (PB), assuming diﬀusion equili-
brium between arterial blood leaving the lung and alveolar air
leaving the lung (eq 2):
= ×C C Part A B (2)
Subsequently, both eqs 1 and 2 can be combined to describe
the alveolar concentration (eq 3). The alveolar concentration
(CA) is proportional to the concentration of the VOC in mixed
venous blood (CV) and the concentration of the VOC present
in inhaled air (Cin), which is associated with the substance-
speciﬁc blood:air partition coeﬃcient (PB), alveolar ventilation
(VA), and cardiac output (QC).
19,20
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When measuring VOCs with a low blood:air partition
coeﬃcient (PB ≤ 10), the concentration in venous blood is
primarily inﬂuenced by the ventilation rate and cardiac output.
Consequently, slight variations in these parameters will lead to
inter and intra individual diﬀerences.21 In contrast, for VOCs
with a high blood:air partition coeﬃcient (PB > 10), the venous
blood concentration is less aﬀected by changes in ventilation
rate and cardiac output. Water-soluble compounds may become
dissolved in the mucous membrane lining the respiratory tract
during inhalation and exhalation (i.e., the wash-in wash-out
eﬀect). This results in a lower uptake of the hydrophilic solvent
compared to what would be expected based on blood:air
partitioning.22,23 The wash-in wash-out eﬀect requires stan-
dardization of the sample collection procedure and an
adjustment for this eﬀect should be considered when modeling
the data.
The collection of samples of end-exhaled air, using canisters,
bags, or glass tubes, is noninvasive, and because of easy
accessibility, repeated samples can be obtained in a short time
period without causing much of a burden to the study
subject.24,25 This makes exhaled air analysis attractive for kinetic
studies.
The aim of this study was to quantify D4 and D5 in end-
exhaled air, as it reﬂects the blood concentration and therefore
internal exposure to D4 and D5. This method was used in a
human exposure study focused on the dermal uptake of D4 and
D5 as a pure substance and as a constituent of night cream or
deodorant.
■ MATERIALS AND METHODS
Chemicals. Octamethylcyclotetrasiloxane (98% D4; CAS
556-67-2) and decamethylcyclopentasiloxane (97% D5; CAS
541-02-6) were obtained from Sigma-Aldrich (St. Louis, MO,
United States). 13C-labeled D4 and 13C-labeled D5, used as
internal standards, were purchased from Dow Corning
(Midland, MI, United States). Methanol (99.9%; CAS 67-56-1)
supplied by Boom (Meppel, The Netherlands) was used to
dissolve 13C-labeled D4 or D5 and unlabeled D4 or D5 for the
preparation of standards. Bio-VOC breath samplers were
obtained from Markes International (Llantrisant, United King-
dom) and automatic thermal desorption (ATD) 0.25 in. × 3.5 in.
stainless steel tubes ﬁlled with Carbograph 2 TD 60/80 and
Carbograph 1 TD 60/80 were obtained from Camsco (Houston,
TX).
Standard Preparation. We prepared a stock solution of
10 μg/μL of D4 and D5 in methanol. From this solution standards
were prepared of 10, 5, 2, 1, 0.5, and 0.1 ng/μL. 13C-labeled D4 and
13C-labeled D5 were diluted with 10 mL of methanol to a stock of
1 μg/μL. Both stock solutions were further diluted and combined
to a working solution of 5 ng/μL.
Sample Collection and Preparation. Prior to use, the
ATD tubes were conditioned at least 4 h at 350 °C using a
multitube conditioner (TC-20, Markes International, Llantrisant,
United Kingdom). End-exhaled breath samples were collected
using Bio-VOC breath samplers. The participants were instructed
to inhale normally, to place the Bio-VOC breath sampler into
their mouth and to exhale fully at normal speed into the sampler.
Immediately following sample collection, the substances of
interest were transferred to an ATD tube using the syringe
Table 1. Chemical Structure and Some Physical Chemical Properties of D4 and D5
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(plunger). The ATD tubes were capped with Swagelock-caps
and stored until analysis at ambient temperature for less than
24 h. Subsequently, 2.5 ng of 13C-labeled D4 and D5 in 0.5 μL of
methanol was loaded on the ATD tubes using a loading rig
(Markes International, Llantrisant, United Kingdom). The ATD
tube was connected to the loading rig, the internal standard
solution was injected using a syringe, and the tube was ﬂushed
with helium 5.0 (Linde Gas, Schiedam, The Netherlands) at a
ﬂow of 50 mL/min for 3 min to remove the methanol.
Calibration Procedure and Quantiﬁcation. Calibration
and quantiﬁcation was carried out by spiking seven ATD tubes
in a concentration range between 0 and 10 ng/μL D4 and D5.
A conditioned ATD tube was connected to the loading rig.
Next, the standards were loaded on the tubes using a syringe
and ﬂushing the tube with helium 5.0 at a ﬂow of 50 mL/min
for 3 min to remove the methanol. Subsequently, this procedure
was repeated for loading of the internal standards. Linear
calibration curves were constructed by plotting the quotient of
the peak area of the analytes of interest and the corresponding
labeled internal standards versus the standard concentrations. The
calibration curves routinely had r2 ≥ 0.99 for both substances.
Analysis. The samples were analyzed by use of thermal
desorption gas chromatography mass spectrometry (TD-GC-MS).
The instrument consisted of a thermal desorption unit and auto
sampler (Unity 2 and Ultra 2, Markes) coupled to a gas
chromatograph mass spectrometer (Focus and ISQ, Thermo
Scientiﬁc, Interscience Breda, The Netherlands). Electron impact
ionization was used. The ATD tubes were inserted in the auto
sampler and subsequently desorbed at 275 °C for 15 min, using a
split ﬂow of 10 mL/min. Samples were trapped at −10 °C by
using a general purpose hydrophobic trap (U-T2GPH-2S). A
30 m Rxi-5 MS (0.25 mm i.d., 0.5 μm ﬁlm thickness, Restek) was
used as an analytical column. Helium 5.0 was used as carrier gas.
The GC oven temperature was programmed as follows: hold for
5 min at 50 °C; 10 °C/min to 150 °C; 30 °C/min to 250 °C, hold
for 2 min. The transfer line was kept at 250 °C and the ion source
at 250 °C. We ran in full scan mode and the ions monitored were
m/z 281 for D4, 355 for D5, 285 for 13C-labeled D4, and 360 for
13C-labeled D5, respectively. The dwell time was set at 0.4 s.
Biological Monitoring. To demonstrate the applicability of
the method for quantifying values at a low range, we collected
end-exhaled air samples (142 mL) in duplicate from 15
consumers exposed to PCPs (regular use) and from the same
consumers after they refrained from the use of PCPs for 24 h.
Regular use was described as the use of PCPs by our volunteers
as they would normally do without restrictions.
■ RESULTS AND DISCUSSION
Prevention of Contamination. The ubiquitous presence
of cyclic siloxanes and their unique chemistry makes their
analysis at trace levels challenging.26 Several measures were
taken to prevent contamination of the analytical process: (1)
D4 and D5 are present in a wide variety of PCPs, such as hand
creams and deodorants. All researchers, lab technicians, and
instrument operators refrained from the use of these products
prior to (24 h) and during the experimental and analytical
work. (2) All calibration and internal standard solutions were
prepared in glass jars with metal-lined screw caps to prevent
contamination of the solutions due to contact with plastic
(possible silicon-containing) screw caps. (3) The initial pressure
regulator, regulating helium ﬂow, was replaced by a pressure
regulator with a complete iron inner lining. (4) All parts of the
TD-GC-MS system that contained silicon were replaced by
silicon-free alternatives (e.g., septa). Before the start of every
Figure 1. Extracted ion chromatogram of D4 (A) and D5 (B) after analysis of the TD-GC-MS system without the presence of samples loaded with
D4 and D5.
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analysis the system was checked with an empty tube, which did
not contain a sorbent, to verify that the system was not a source
of background contamination (Figure 1A,B).
Conditioning. ATD tubes, conditioned by the supplier with
nitrogen, appeared to contain substantial amounts of D4 and
D5 upon arrival. Helium 4.5 was used to condition the ATD
tubes, but the D4 and D5 levels present on the tubes did not
decrease. To improve the precleaning eﬃciency, helium 4.5 was
replaced by helium of superior quality (helium 5.0). Despite
extensive conditioning, we were unable to completely remove
all D4 and D5. Conditioning was considered satisfactory if the
residual background level for both substances was present on
the tubes, corresponding to <69 pg/tube for D4 and <47 pg/tube
for D5. As the analytical system itself was not a source of
contamination, we suggest that D4 and D5 were diﬃcult to
remove completely as they originated from the adsorbent
material in the tubes. We accounted for this problem by
analyzing each individual conditioned tube and subtracting the
peak areas of the analytes on the tube prior to sample collection
from the peak areas observed in the ﬁnal analysis of a tube
loaded with end-exhaled air.
Quantiﬁcation limit. The limit of quantiﬁcation (LOQ)
was determined to be the concentration at which the
repeatability has a coeﬃcient of variation of ≤25% (Figure 2).
The LOQ was 2.1 ng/L end-exhaled air (0.3 ng/tube) for D4
and 1.4 ng/L end-exhaled air (0.2 ng/tube) for D5.
Repeatability of the Method. This method shows well
resolved peaks without interference (Figure 3A,B).
Repeatability for both substances improved due to the
addition of an internal standard. The coeﬃcient of variation
decreased from 30.8% to 9.5% for D4 and from 37.8% to 12.5%
for D5. Over a period of months, the slope of the calibration
curves showed a small variation as the coeﬃcient of variation
was 7.0% for D4 and 10.4% for D5. To take this variation in
account, in each series of samples standards were analyzed. The
inter- and intraday variations were similar for both substances
(Table 2).
Breakthrough and Collection Eﬃciency. With this
experimental setup, it was unlikely that breakthrough of D4
and D5 would occur as the concentrations present in the end-
exhaled air samples were rather low. The siloxanes collected
using the Bio-VOC breath sampler were transferred to the
ATD tubes with a mean eﬃciency of 96% (±3%).
Presence of Water in End-Exhaled Air Samples. In a
recent article by Guallar-Hoyas and co-workers,27 it was
suggested that the presence of water in breath samples, when
thermally desorbed, could damage the stationary phase of the
GC column and lead to the production of cyclic siloxanes due
to hydrolysis. Consequently, the retention times and
separations were not reproducible across analytical campaigns.
Figure 2. Coeﬃcient of variation versus the D4 and D5 concentration
in end-exhaled air.
Table 2. Inter- and Intraday Variability Expressed as
Coeﬃcient of Variation
interday intraday
concentration (ng/tube) N D4 (%) D5 (%) N D4 (%) D5(%)
1 17 22.7 15.9 5 25.4 22.4
5 16 8.8 12.8 6 9.5 12.5
Table 3. Mean Concentrations of D4 and D5 in End-Exhaled
Air Collected from Human Volunteers Who Used PCPs and
from the Same Study Participants Not Using PCPs for 24 h
Prior to Sample Collection
regular use of PCPs
no use of PCPs for 24 h prior
to sample collection
D4 (ng/L) ﬁrst sample second sample ﬁrst sample second sample
1 2.1 4.3 2.8 3.8
2 7.7 6.4 <2.1 <2.1
3 9.1 20.0 <2.1 2.9
4 2.7a 10.8 <2.1 4.0
5 2.4 3.9 2.5 <2.1
6 2.1 3.3 <2.1 <2.1
7 3.4 5.2 <2.1 <2.1
8 2.4 <2.1 8.7a <2.1
9 3.8a 13.1 <2.1 <2.1
10 <2.1 2.5 3.1 <2.1
11 18.0 5.6 <2.1 <2.1
12 11.2a 43.5 <2.1 <2.1
13 10.9 2.2 <2.1 <2.1
14 2.3 3.4 2.2 <2.1
15 86.4 3.1a <2.1 <2.1
regular use of PCPs
no use of PCPs for 24 h prior
to sample collection
D5 (ng/L) ﬁrst sample second sample ﬁrst sample second sample
1 2.9 3.4 5.2 1.8
2 9.2 3.9 <1.4 <1.4
3 23.2 13.3 3.3 <1.4
4 1.4 1.8 5.8 2.0
5 2.0 1.7 <1.4 3.3
6 2.7 3.0 <1.4 <1.4
7 17.0a 37.3 1.9 2.8
8 3.7 1.9 <1.4a 18.5
9 4.9a 83.8 <1.4 <1.4
10 <1.4 4.7 <1.4 1.8
11 3.2 <1.4 <1.4 <1.4
12 10.4 55.9 <1.4 <1.4
13 3.0 <1.4 <1.4 1.7
14 6.8 2.1 <1.4 <1.4
15 34.1 1.6a <1.4 <1.4
aNote that there is a rather large diﬀerence between the two samples
collected. The lowest value is probably not representing the D4 or D5
concentration in alveolar air, as the volunteer did not exhale
completely. The value is representing the D4 or D5 concentration
present in air which consists of a combination of air present in the
death space of the lungs and in the alveoli.
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We believe that the presence of water in our end-exhaled air
samples did not interfere with the stationary phase. The
method presented in this paper has been used to assess the D4
and D5 content of approximately 1300 end-exhaled air samples
obtained in various experiments. The samples have been
analyzed between March and August 2013 and the retention
times were stable during this period. Furthermore, when
loading the internal standard, the tube was purged with helium
for 3 min, and directly at the start of the TD-GC-MS program,
the tube was dry-purged for 1 min to remove excess water.
Results of Biological Monitoring. Table 3 shows the
results of end-exhaled air samples, collected from 15 volunteers
who were using PCPs (regular use) and from the same
consumers who refrained from the use of PCPs for 24 h. The
cyclic siloxanes investigated were indicated on the ingredient
labels of the PCPs used by the volunteers. All samples were
Figure 3. TD-GC-MS chromatogram and the EI-mass spectra of D4 (A) and D5 (B), analysis of a sample provided by a volunteer who was exposed
to PCPs on a regular basis.
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collected in duplicate. The mean concentration in end-exhaled
air ranged from 2 to 45 ng/L for D4 and from 2 to 44 ng/L for
D5 following regular use of PCPs. The mean concentration of
the cyclic siloxanes in end-exhaled air of consumers who did
not apply any PCPs for 24 h was below 4 ng/L for D4 and
below 9 ng/L for D5. When volunteers refrained from the use
of PCPs 24 h prior to sample collection, the mean D4 and D5
concentration in end-exhaled air was, in most cases, similar or
lower compared to the mean concentration measured after
regular use of PCPs. Table 3 shows one exception (volunteer
number 8), which may be explained by inhalation exposure to
ambient sources of D4 and D5 while using public trans-
portation to our laboratory. A signiﬁcant diﬀerence was found
between the D4 concentration in end-exhaled air of volunteers
who did not use personal care products for 24 h and of the
same volunteers who regularly used PCPs (P = 0.009). For D5
also a diﬀerence was found, but failed to reach the 5% level of
signiﬁcance (P = 0.078), probably because of the small sample
size.
■ CONCLUSION
Analysis of end-exhaled air represents a new and promising
noninvasive approach in the use of D4 and D5 as chemical
markers of cyclic siloxanes in consumer and environmental
exposure assessment. Cyclic siloxanes (D4 and D5) can be
quantiﬁed in end-exhaled air at concentration levels as low as
background levels observed in the general population. To our
knowledge, this is the ﬁrst method describing the use of
TD-GC-MS as an analytical technique to quantify cyclic
siloxanes in end-exhaled air.
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